Canonical Inhibitor-like Interactions Explain Reactivity of α1-Proteinase Inhibitor Pittsburgh and Antithrombin with Proteinases

Alexey Dementiev, Miljan Simonović, Karl Volz, Peter G.W. Gettins

Journal of Biological Chemistry · 2003 · 89 citations · 21 references

DOIFull text

Open access

Concepts

Abstract

The serpin antithrombin is a slow thrombin inhibitor that requires heparin to enhance its reaction rate. In contrast, α1-proteinase inhibitor (α1PI) Pittsburgh (P1 Met → Arg natural variant) inhibits thrombin 17 times faster than pentasaccharide heparin-activated antithrombin. We present here x-ray structures of free and S195A trypsin-bound α1PI Pittsburgh, which show that the reactive center loop (RCL) possesses a canonical conformation in the free serpin that does not change upon binding to S195A trypsin and that contacts the proteinase only between P2 and P2′. By inference from the structure of heparin cofactor II bound to S195A thrombin, this RCL conformation is also appropriate for binding to thrombin. Reaction rates of trypsin and thrombin with α1PI Pittsburgh and antithrombin and their P2 variants show that the low antithrombin-thrombin reaction rate results from the antithrombin RCL sequence at P2 and implies that, in solution, the antithrombin RCL must be in a similar canonical conformation to that found here for α1PI Pittsburgh, even in the nonheparin-activated state. This suggests a general, limited, canonical-like interaction between serpins and proteinases in their Michaelis complexes. The serpin antithrombin is a slow thrombin inhibitor that requires heparin to enhance its reaction rate. In contrast, α1-proteinase inhibitor (α1PI) Pittsburgh (P1 Met → Arg natural variant) inhibits thrombin 17 times faster than pentasaccharide heparin-activated antithrombin. We present here x-ray structures of free and S195A trypsin-bound α1PI Pittsburgh, which show that the reactive center loop (RCL) possesses a canonical conformation in the free serpin that does not change upon binding to S195A trypsin and that contacts the proteinase only between P2 and P2′. By inference from the structure of heparin cofactor II bound to S195A thrombin, this RCL conformation is also appropriate for binding to thrombin. Reaction rates of trypsin and thrombin with α1PI Pittsburgh and antithrombin and their P2 variants show that the low antithrombin-thrombin reaction rate results from the antithrombin RCL sequence at P2 and implies that, in solution, the antithrombin RCL must be in a similar canonical conformation to that found here for α1PI Pittsburgh, even in the nonheparin-activated state. This suggests a general, limited, canonical-like interaction between serpins and proteinases in their Michaelis complexes. Although antithrombin is the principal inhibitor of the blood coagulation proteinases thrombin and factor Xa, its rate of reaction with each of these proteinases is slow in the absence of heparin (1Olson S.T. Björk I. Sheffer R. Craig P.A. Shore J.D. Choay J. J. Biol. Chem. 1992; 267: 12528-12538Abstract Full Text PDF PubMed Google Scholar, 2Olson S.T. Björk I. J. Biol. Chem. 1991; 266: 6353-6364Abstract Full Text PDF PubMed Google Scholar). In marked contrast, a variant of the serpin α1-proteinase inhibitor that contains a P1 mutation of methionine to arginine, named α1PI 1The abbreviations used are: α1PI, α1-proteinase inhibitor; BPTI, basic pancreatic trypsin inhibitor; RCL, reactive center loop; 5-mer, pentasaccharide heparin that binds to antithrombin with high affinity; MOPS, 4-morpholinepropanesulfonic acid. Pittsburgh, was found to be a very effective inhibitor of thrombin, with a second order rate constant for thrombin inhibition 17-fold higher than that of antithrombin that had been conformationally activated by pentasaccharide heparin (3Travis J. Matheson N.R. George P.M. Carrell R.W. Biol. Chem. Hoppe-Seyler. 1986; 367: 853-859Crossref PubMed Scopus (27) Google Scholar, 4Owen M.C. Brennan S.O. Lewis J.H. Carrell R.W. N. Engl. J. Med. 1983; 309: 694-698Crossref PubMed Scopus (323) Google Scholar). In the individual who carried the Pittsburgh mutation, the potent thrombin inhibitory capability of this variant serpin resulted in hemorrhage and ultimately death. In antithrombin, heparin is a multifactorial enhancer that can not only act as a bridging cofactor to bring serpin and proteinase together but can also induce a conformational change in antithrombin that results in expulsion of the two distal residues of the RCL from β-sheet A (5Huntington J.A. Olson S.T. Fan B. Gettins P.G.W. Biochemistry. 1996; 35: 8495-8503Crossref PubMed Scopus (126) Google Scholar, 6Jin L. Abrahams J.P. Skinner R. Petitou M. Pike R.N. Carrell R.W. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 14683-14688Crossref PubMed Scopus (638) Google Scholar). It has been proposed that this loop expulsion permits alteration of the RCL conformation in the vicinity of the scissile bond to a more optimal one for interaction with proteinase and so contributes significantly to the heparin-induced acceleration of proteinase inhibition. In keeping with this proposal, the RCL conformation of antithrombin in published x-ray structures has the P1 arginine residue turned inwards toward the body of the protein, where it forms a salt bridge to Glu255 (7Schreuder H.A. de Boer B. Dijkema R. Mulders J. Theunissen H.J.M. Grootenhuis P.D.J. Hol W.G.J. Nat. Struct. Biol. 1994; 1: 48-54Crossref PubMed Scopus (270) Google Scholar, 8Carrell R.W. Stein P.E. Fermi G. Wardell M.R. Structure. 1994; 2: 257-270Abstract Full Text Full Text PDF PubMed Scopus (369) Google Scholar). However, these x-ray structures are all of antithrombin dimers that contain one molecule of functionally active antithrombin and one in an inactive, latent conformation. Importantly, the RCL of the functional molecule forms the interface with the latent molecule, as an extra strand of β-sheet C of that molecule. This raises the question of whether the conformation of the active molecule has been artificially altered by heterodimer formation and thus of whether it represents the conformation of antithrombin in solution. In an attempt to understand the structural basis for α1PI Pittsburgh being able to inhibit thrombin at a high rate, and thus also to provide insight into the low basal reactivity of antithrombin, we have determined crystal structures of free and S195A trypsin-bound forms of the Pittsburgh variant of the serpin α1-proteinase inhibitor and correlated these with rate constants for inhibition of thrombin and trypsin by α1PI Pittsburgh, by antithrombin, and by P2 variants of each of these serpins. Protein Expression and Purification—α1PI Pittsburgh, containing seven stabilizing mutations that hinder polymerization (9Lee K.N. Park S.D. Yu M.H. Nat. Struct. Biol. 1996; 3: 497-500Crossref PubMed Scopus (61) Google Scholar) and a C232S mutation that prevents intermolecular disulfide bond formation, was expressed and refolded as previously described (10Peterson F.C. Gordon N.C. Gettins P.G.W. Biochemistry. 2000; 39: 11884-11892Crossref PubMed Scopus (35) Google Scholar). The P2 Pro → Gly variant was made by site-directed mutagenesis and expressed and purified as for α1PI Pittsburgh. S195A bovine trypsinogen was expressed in Escherichia coli as inclusion bodies and refolded, purified, and activated as previously described (11Peterson F.C. Gordon N.C. Gettins P.G.W. Biochemistry. 2001; 40: 6275-6293Crossref PubMed Scopus (33) Google Scholar). The noncovalent complex between S195A trypsin and α1PI Pittsburgh was formed at pH 7.5 in 25 mm Tris-HCl, 50 mm NaCl, and the complex was purified on Superdex 200 (Amersham Biosciences), dialyzed, and concentrated to 15 mg ml–1 in 10 mm MOPS, pH 6.0, containing 25 mm NaCl. Crystallization, Data Collection, Structure Determination, and Refinement—α1PI Pittsburgh crystals were obtained at 20 °C using the hanging drop method, by mixing equal volumes of protein (25 mg/ml) and well solutions (0.2 m potassium citrate, 20% polyethylene glycol 3350, pH 6.30). An irregular rod-shaped crystal (0.9 × 0.25 × 0.1 mm) grew within 1 month. Diffraction data were collected at room temperature from a single crystal on a Rigaku RAXIS II detector, with a Rigaku RU-H2R rotating anode x-ray generator. Data were indexed with DENZO and scaled and reduced with SCALEPACK. Initial phases were determined by molecular replacement using the structure of wild type α1PI (1QLP). Molecular replacement calculations were performed with CNS. Electron density maps were interpreted using Quanta. The model was progressively refined using simulated annealing at constant temperature, followed by energy minimization and manual inspection and rebuilding. 22 N-terminal amino acids and the histidine tag were not visible in the final electron density maps. Crystallographic data and statistics are shown in Table I.Table IData collection and refinement statistics for α 1PI Pittsburgh and α 1PI Pittsburgh-S195A trypsin noncovalent complexα1PI Pittsburghα1PI Pittsburgh-S195A trypsinCrystalSpace groupP212121C2Cell dimensionsa = 39.31 Åa = 132.2 Åb = 52.16 Åb = 62.3 Åc = 208.68 Åc = 98.9 Åβ = 110.3 °No. of crystals12Data collectionTemperature298K100KResolution limit (Å)100-2.65100-2.3Wavelength (Å)1.5411.00Reflections (observed/unique)103,240/12,840628,540/33,539Completeness (overall/last shell) (%)96.7/93.699.5/99.7R merge (overall/last shell) (%)10.3/56.49.6/24.5I/σI (overall/last shell)15.9/2.717.6/4.1RefinementNo. of molecules (complexes) in asymmetric unit11Resolution range (Å)40.00-2.6540.00-2.30Average B-factor (Å2)50.651.5No. of reflections (work/test)11,125/1,25629,499/3,277No. of protein atoms (amino acids)2,786 (371)4,542 (598)No. of solvent molecules123377R cryst (%)18.818.9R free (%)19.322.8Root mean square deviations from idealityBond lengths (Å)0.0060.006Bond angles (degrees)1.31.3Ramachandran statisticsMost favored277 (83.7%)524 (87.6%)Additionally allowed51 (15.4%)73 (12.2%) Open table in a new tab S195A trypsin-α1PI Pittsburgh complex crystals (0.15 × 0.20 × 0.20 mm) were obtained within 10 days at 18 °C from hanging drops in 0.2 m potassium citrate buffer, pH 8.3–8.5, containing 17.5% (w/v) polyethylene glycol 3350 and 2% glycerol. Diffraction data were collected from two single, flash frozen, crystals, cryoprotected in oil, using synchrotron radiation at the SERCAT beamline (Advanced Photon Source, Argonne National Laboratory). Data were indexed and processed as described above. The structure of the complex was solved by molecular replacement using CNS programs with the structures of human α1PI (1QLP) and bovine trypsin (1EJM) as search models. The final refined model of the complex was obtained as described for α1PI Pittsburgh. Statistics are given in Table I. Kinetic Measurements—Inhibition of trypsin by α1PI Pittsburgh was followed at 25 °C by progress curve analysis using a continuous assay. 1 nm trypsin was mixed with 10–50 nm α1PI Pittsburgh in 10 mm sodium phosphate, pH 7.40, 2 mm EDTA, 0.1 m NaCl, 0.1% polyethylene glycol 8000, containing 250 μm S-2222 chromogenic substrate. Product release was followed by change in absorbance at 405 nm. Curves obtained at different α1PI concentrations were fitted by a single exponential function with Sigma-Plot software, and values for k were where and are the concentrations of α1PI and The rate constant was obtained from the The Pro → Gly α1PI Pittsburgh complex had very low The rate of complex formation was determined from analysis of the reaction obtained where of the complex was A. Carrell R.W. J.A. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Scholar). The α1PI Pittsburgh P2 Gly variant (0.2 was mixed with trypsin at room temperature in 10 of were at from to the reaction was by mixing with 10 of reduced and for 2 and reaction were by were determined by and to The rate constant was determined from the of a of where represents serpin and is The rate of thrombin inhibition by the variant was determined by assay. 25 nm thrombin was mixed with 250 nm α1PI Pittsburgh, and the proteinase was determined at by the reaction into containing μm chromogenic substrate. proteinase was and by in Sigma-Plot using the = k The second order rate was determined by k by the α1PI of of inhibition of α1PI Pittsburgh variant for thrombin was determined by proteinase the the serpin with 200 nm thrombin in at 25 °C and the to to thrombin was determined by the reaction with containing μm and the rate of at 405 nm. The of inhibition of α1PI Pittsburgh for trypsin was determined that of trypsin was by the reaction into containing 250 μm Structure of the α Pittsburgh-S195A the reaction be at the of the noncovalent Michaelis this complex is to be by the noncovalent complex formed between the S195A of the proteinase and the We have determined the structure of a complex formed between S195A trypsin and the serpin α1PI Pittsburgh The α1PI Pittsburgh RCL in the complex had a canonical conformation similar to that found previously for serpin Carrell R.W. Abrahams J.P. Nat. Struct. Biol. 1996; 3: PubMed Scopus Google Scholar, Abrahams J.P. J. Biol. PubMed Scopus Google Scholar). the active of the proteinase with the serpin RCL, on the scissile contacts were present between the serpin body and the the noncovalent complex of heparin cofactor with S195A thrombin. the high of the α1PI Pittsburgh-S195A trypsin complex Gettins P.G.W. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: PubMed Scopus Google contacts between the serpin RCL and the proteinase are the P1 arginine has interaction with the being in the The contacts between the of serpin residues P2 to with atoms of the in a to that of canonical proteinase R. J. 1992; PubMed Scopus Google Scholar). This from an structure of S195A trypsin with serpin which contacts between more distal of the RCL and of trypsin that were to be for binding S. R. M. Nat. Struct. Biol. 2001; PubMed Scopus Google Scholar). We a for in which the interaction of the serpin with S195A trypsin is to that of BPTI, and the serpin has an RCL conformation on that of the interaction loop of Structure of α also determined the x-ray crystal structure of α1PI Pittsburgh and found between the structure of the free serpin and the serpin in noncovalent complex with S195A The serpin body in the two with mean square of only for This of conformational change for the serpin body and the trypsin upon complex is had been found previously from for the complex (10Peterson F.C. Gordon N.C. Gettins P.G.W. Biochemistry. 2000; 39: 11884-11892Crossref PubMed Scopus (35) Google Scholar, F.C. Gordon N.C. Gettins P.G.W. Biochemistry. 2001; 40: 6275-6293Crossref PubMed Scopus (33) Google Scholar). within the RCL, the only were in the where the loop the serpin from the scissile to which the of the that with S195A were in free and This RCL conformation was also very similar to that of α1PI, which has previously been to have a canonical conformation Carrell R.W. Abrahams J.P. Nat. Struct. Biol. 1996; 3: PubMed Scopus Google Scholar, Abrahams J.P. J. Biol. PubMed Scopus Google Scholar). of RCL this conformation of the RCL of α1PI Pittsburgh also into the active of thrombin for structural change was from a of the present structure with the x-ray structure of the noncovalent complex of S195A thrombin with the serpin heparin cofactor II Carrell R.W. F.C. J.A. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). The of heparin cofactor II and of antithrombin are and Although the P1 residue of heparin cofactor II is a residue than arginine, it is a serpin for with α1PI Pittsburgh, in to serpins being thrombin have P2 residues and and the P1 of heparin cofactor II the of S195A thrombin in the that arginine in α1PI Pittsburgh does in noncovalent complex with S195A of the of α1PI Pittsburgh and heparin cofactor from their noncovalent with S195A that the are in the the scissile bond the P1 which is very different in the two in the so as to in the in of α 1PI Pittsburgh RCL into trypsin and thrombin have the significantly at the to the active trypsin has thrombin has two one on of the active that limit and are to to the protein of thrombin. to the x-ray structure of the noncovalent complex of thrombin with BPTI, it was that thrombin conformational change in binding to all of the structures of thrombin with low molecular had shown the conformation for the as well as for the The structure of the a of the and which of to the active de A. R. J. 1997; PubMed Scopus Google Scholar). This for the binding energy of the complex with the In the heparin cofactor thrombin noncovalent these are also to thrombin, to a different than in the complex It is that a similar of these α1PI Pittsburgh to with thrombin in a binding canonical-like for the α1PI Pittsburgh RCL conformation. of RCL into RCL conformation of antithrombin found in all x-ray structures is different from that of α1PI Pittsburgh and from heparin cofactor II that be very between thrombin and an antithrombin RCL that had a conformation in a the RCL of antithrombin a conformational change to that of α1PI Pittsburgh and to be able to with thrombin. of Reaction of α 1PI Pittsburgh and with and of the rates of of by thrombin, and factor has shown that the rates of of by trypsin show very on residues for of thrombin, is very higher at the P2 L. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). change of the P2 residue from Pro to Gly results in change in rate for by trypsin but a in rate for by thrombin. whether the of is shown in the more RCL of α1PI Pittsburgh, we a P2 Pro → Gly variant of α1PI Pittsburgh and the rates of reaction of the P2 Pro and P2 Gly forms of the serpin with trypsin and thrombin. reaction with α1PI variants similar rates of as was with In the values of the rate constants were than 1 order of than for the reaction with thrombin, a similar was between rates of and serpin reaction for these two α1PI α1PI Pittsburgh faster than the P2 Gly which was similar to the In the values of the rate constants only a between free and serpin RCL than the with order rate constants for inhibition of thrombin and trypsin by α 1PI Pittsburgh and rate constants have been for of inhibition from from from × × × × × × × × × × × × × × × × rate constants have been for of inhibition J.A. Gettins P.G.W. Biochemistry. 1994; PubMed Scopus Google Data from R. Olson S.T. J. Biol. Chem. 2001; Full Text Full Text PDF PubMed Scopus Google Data from L. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Open table in a new tab with the α1PI Pittsburgh antithrombin as faster with trypsin thrombin The antithrombin RCL conformation in this is to more change in conformation to be able to to of these proteinases than does α1PI Pittsburgh. for the P2 Pro variant of antithrombin bound to heparin the rate of reaction with thrombin is the as for the reaction of α1PI Pittsburgh, change in conformation upon it is that the rate of reaction of antithrombin with thrombin is in the absence of heparin pentasaccharide than in its the is only for the and a more for the P2 Pro variant of proteinases by serpins noncovalent binding of the proteinase to the RCL of the followed by of the active on the bond of the The for inhibition is formation of the complex that of the proteinase active with the serpin RCL P.G.W. Chem. PubMed Scopus Google Scholar). on the x-ray structures of α1PI Pittsburgh, and in noncovalent complex with S195A trypsin and on structures of α1PI, we can that the of these serpins are in a canonical conformation to with trypsin and the This for the high of the noncovalent and the very high rates of reaction with active trypsin and for the Pittsburgh and Although we not the structure of the noncovalent complex of α1PI Pittsburgh with S195A thrombin, the of a structure for heparin cofactor to the RCL of heparin cofactor II in complex with S195A thrombin with that of α1PI Pittsburgh in complex with S195A on a of conformation of the two it is that α1PI Pittsburgh also an canonical noncovalent complex with thrombin for change in conformation of the RCL with that in the free state. In contrast, the conformation of the antithrombin RCL from published x-ray structures is and not into the active of thrombin This energy and in a rate for formation of this complex with its formation by α1PI Pittsburgh. this is not the for P2 Gly P2 Pro forms of antithrombin with the α1PI Pittsburgh suggests that the conformation of the antithrombin RCL the scissile bond is not that in the crystal structure but is that of α1PI Pittsburgh and requires conformational change to to thrombin. results also that, for α1PI Pittsburgh, the in rate upon replacement of at P2 by is not a of conformational the free show a similar rate the rate of reaction of α1PI Pittsburgh with thrombin is only than with it is that the RCL are the as found for the of with S195A thrombin and α1PI Pittsburgh with S195A trypsin and that the rate results from the to bring the of of the and of thrombin as was in the thrombin noncovalent these rate that the RCL of α1PI Pittsburgh, with P2 Pro P2 has the canonical conformation in with S195A trypsin and S195A thrombin and that in rates of reaction from in P2 contacts in thrombin and from the to the and of thrombin to the serpin A similar can be with to antithrombin, thus an to the question of α1PI Pittsburgh is a faster inhibitor of thrombin than antithrombin. the in the rate of inhibition of thrombin by antithrombin upon the P2 Gly to Pro the in α1PI Pittsburgh and free it the in contacts between the and and thrombin, than in conformation of the of the two serpins. α1PI Pittsburgh is a faster inhibitor of thrombin than antithrombin it has a at P2 than the that is present in antithrombin. antithrombin in the absence of the in the rate of reaction with thrombin are to from conformational between and antithrombin in the vicinity of the scissile bond but from the on the RCL in the by the of two RCL and in the β-sheet A. a of a bound to at P1 as a replacement for arginine that the a in and forms of antithrombin A. Gettins P.G.W. Biochemistry. 2001; 40: PubMed Scopus Google Scholar). The that the upon heparin binding results from a of of the as a of of the RCL from the serpin but for a change in conformation at and to the of of that α1PI Pittsburgh with S195A trypsin to canonical as had been by and Carrell R.W. Abrahams J.P. Nat. Struct. Biol. 1996; 3: PubMed Scopus Google Scholar, Abrahams J.P. J. Biol. PubMed Scopus Google and the that this of interaction is also used in two noncovalent of heparin cofactor II with S195A thrombin and M. serpin with S195A raises the question of serpins different from canonical The present show that the is not to a in the conformation of the to In of the RCL of canonical can is not a between these of the to be in the of the between the and forms of the canonical the constant between and forms is to 1 at that is energy between these two as a of the on the In of the RCL at the the that the RCL as a loop at the of the molecule. the serpin conformation in which the RCL has into β-sheet A is very more than that in which it is an toward the the has been of this energy is used to the proteinase and it is a of the of the serpin However, it not from the that in their interaction with the even to formation, are as canonical This has to the question of the serpin inhibitory have the on the serpin for the to the serpin must into a that the loop that reactive center loop is of is the rate at which loop must be that of the proteinase and of the proteinase must to with the of of the residues within the of the RCL that slow slow an of β-sheet A to the RCL be to the its It is to that all of the structural by a serpin to it serpins more by a of of this It is that a which have had an had an loop that with a proteinase but was not to inhibit it within the of the loop and within and β-sheet A have of the which have reduced the conformational of the loop and made it into a canonical inhibitor is for in within the serpin body have upon of the scissile bond and the of of the in a of have to more the all serpins thus more canonical with to into β-sheet it be that serpins are not able to be these serpins and be of the canonical This be residues within the RCL conformational A is which of loop upon RCL but has a well RCL that contains at and M. Gettins P.G.W. Proc. Natl. Acad. Sci. U. S. A. 2001; PubMed Scopus Google Scholar). Data on the noncovalent complex were collected on the SERCAT beamline at the Photon Source, We Olson for

References

21